tiprankstipranks
Circio Holding ASA Unveils Breakthrough in Gene Therapy
Company Announcements

Circio Holding ASA Unveils Breakthrough in Gene Therapy

Targovax ASA (GB:0RIS) has released an update.

Pick the best stocks and maximize your portfolio:

Circio Holding ASA has announced significant advancements in its circVec circular RNA expression platform, showcasing a 15-fold increase in protein expression compared to traditional mRNA-based vectors. Presented at the prestigious ESGCT annual meeting, these findings highlight the potential of circVec technology to redefine gene therapy standards. The company is currently testing the platform in various disease settings to guide future development and partnerships.

For further insights into GB:0RIS stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks European Auto-Generated NewsdeskCircio CTO Exercises Warrants Amidst RNA Tech Advances
TipRanks European Auto-Generated NewsdeskCircio Holding ASA Expands Share Capital Amid Therapeutics Focus
TipRanks European Auto-Generated NewsdeskCircio CEO Exercises Warrants Amid Biotech Advancements
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App